Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03080597 · ClinicalTrials.gov registry record · NA
PrEP for HBCUs (Study 2)
A NA study of At Risk for HIV, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT03080597 is a NA study of At Risk for HIV that has completed, run by Duke University. The registered enrollment target is 16 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03080597, a NA study of At Risk for HIV, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators' overall goals are to target (a) pre-exposure prophylaxis (PrEP) uptake by addressing access and acceptability and (b) PrEP adherence among Historically Black Colleges and Universities (HBCU) students.
Conditions Studied
Interventions
- DEVICE PrEP Smart app
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2018-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03080597
The ClinicalTrials.gov registry entry for NCT03080597 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with At Risk for HIV appearing as the primary indexed condition, and to 1 intervention - of which PrEP Smart app is the first listed.
NCT03080597 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03080597 about?
NCT03080597 is a clinical study titled "PrEP for HBCUs (Study 2)". The investigators' overall goals are to target (a) pre-exposure prophylaxis (PrEP) uptake by addressing access and acceptability and (b) PrEP adherence among Historically Black Colleges and Universities (HBCU) students.
What is the current status of trial NCT03080597?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-03-01. Estimated completion is 2018-10-01.
What conditions does trial NCT03080597 study?
This clinical trial studies the following conditions: At Risk for HIV.
What interventions are being tested in trial NCT03080597?
The interventions under investigation include: PrEP Smart app (DEVICE).
Who is sponsoring clinical trial NCT03080597?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03080597 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.